Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Dean Y. Li

Dean Y. Li

President, Merck Research Laboratories

Appears in 1 story

Stories

The first personalized cancer vaccine reaches pivotal testing

New Capabilities

Overseeing Merck's post-Keytruda pipeline strategy

Cancer vaccines have promised to train the immune system against tumors for decades. None has delivered a durable, replicable benefit until now.

Updated May 22